NCT06817473

Brief Summary

  • Statement of the Research Study. Participants are being invited to volunteer to take part in our research study. It is up to participants whether to choose to take part or not. There will be no penalty or loss of benefits to choosing not to take part or decide later not to take part.
  • Purpose. The reason that the researchers are doing this research is to evaluate the effectiveness and feasibility of administering a computerized anxiety intervention in a setting of five or more individuals. This intervention has already been tested and shown promise with individuals, and researchers want to see if it will function in a group setting as well.
  • Duration. Researchers think that taking part in our study will last approximately two hours, with an additional follow-up survey one month later to be completed at home via computer or smartphone.
  • Research Activities. Participants will first be asked to complete several questionnaires dealing with your thoughts and feelings. Once these questionnaires are completed, participants will be assigned to one of two groups, with each group viewing one of two computerized presentations and completing some group exercises afterward. Once participants have completed the designated intervention, participants will then be asked to fill out surveys once again, which will complete the study appointment. One month following the appointment, participants will be sent surveys once again and will be asked to complete them at home. Risks: The risks or discomforts to participants while taking part in this research include temporary distress or anxiety pr potentially feeling mild discomfort answering questions about your thoughts and feelings. Benefits: As a result of taking part in this research, participants may experience improvements in mental health.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
73

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Feb 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 21, 2024

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 15, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 15, 2025

Completed
12 days until next milestone

First Submitted

Initial submission to the registry

January 27, 2025

Completed
14 days until next milestone

First Posted

Study publicly available on registry

February 10, 2025

Completed
Last Updated

February 10, 2025

Status Verified

January 1, 2025

Enrollment Period

11 months

First QC Date

January 27, 2025

Last Update Submit

February 5, 2025

Conditions

Outcome Measures

Primary Outcomes (5)

  • Anxiety Sensitivity Index-3

    18 item self-report measure indexing anxiety sensitivity (Taylor et al., 2007). Scores range from 0-72 with higher scores indicating more severe anxiety sensitivity

    Baseline through Month 1 follow up

  • PROMIS Anxiety Scale 8a

    8-item self-report measure indexing overall anxiety (Pilkonis et al., 2011). Scores range from 8 to 40 with higher scores reflecting worse anxiety symptoms.

    Baseline through Month 1 Follow Up

  • PROMIS Depression Scale 8b

    8 item self-report measure indexing depressive symptoms (Polkonis et al., 2014). Scores range from 8-40 with higher scores reflecting worse depression symptoms.

    Baseline through Month 1 Follow Up

  • Treatment Acceptability Questionnaire

    7-item self-report measure used in prior studies (Short et al., 2017). Scores range from 0-21 with higher scores indicating more favorable acceptability ratings.

    Baseline through Month 1 follow up

  • Treatment Engagement Questionnaire

    Participants were given two items assessing how frequently they: 1) thought about CAST content in the past month; 2) engaged in interoceptive exposure practice.

    Month 1 Follow Up

Secondary Outcomes (3)

  • Intolerance of Uncertainty-12

    Baseline through Month 1 follow up

  • Client Satisfaction Questionnaire

    Baseline through Month 1 Follow Up

  • Difficulties in Emotion Regulation Scale

    Baseline through Month 1 follow up

Other Outcomes (2)

  • Group likingness/closeness

    Baseline

  • Berlin Numeracy Test

    Baseline

Study Arms (2)

CAST

EXPERIMENTAL

Computerized anxiety sensitivity treatment (CAST), which has been used by researchers already in many RCTs. This involves 30 minutes of psychoeducational video material delivered via computer presentation followed by 30 minutes of repeated interoceptive exposure practice exercises such as 60 seconds of breathing through a coffee straw, shaking head from side to side, and looking into a mirror.

Behavioral: CAST

HET

PLACEBO COMPARATOR

Developed as a 30-minute online intervention that provides education about physical health habits that can impact mental health, such as diet, exercise, and sleep. This intervention has been used in prior clinical trials to control for effects of general education, general coping techniques, and use of technology. Participants in past clinical trials have reported that HET is engaging and beneficial.

Behavioral: HET

Interventions

CASTBEHAVIORAL

CAST is a transdiagnostic cognitive behavioral therapy (CBT)-based protocol designed to address elevated AS, particularly the amplification of cognitive stress symptoms including perceived confusion and memory problems. CAST is a fully computerized, 1-hour intervention. CAST contains video animation and audio narration throughout, as well as interactive features (e.g., brief quizzes to promote comprehension). Procedures draw heavily on standard CBT techniques; AS, a core vulnerability for anxiety and depression is targeted using these procedures. In this study, participants complete CAST as a group alongside other participants.

Also known as: Computerized Anxiety Sensitivity Treatment
CAST
HETBEHAVIORAL

The HET protocol covers standard healthy lifestyle behaviors as well as broad coping strategies to address stress. HET is a fully computerized 1-hour control condition focused on increasing healthy behaviors and decreasing unhealthy behaviors. Content includes healthy eating, hydration, sleep and rest, stress management as well as other healthy lifestyle tips. HET was administered in a group format for this study.

Also known as: Health Education Treatment, HEC, Health Education Control
HET

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • adults aged 18+ and ability to use a computer or smartphone.

You may not qualify if:

  • inability to engage in any interoceptive exercises.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Florida State University Psychology Clinic

Tallahassee, Florida, 32304, United States

Location

Related Publications (1)

  • Schubert FT, Morabito DM, Schmidt NB. Examining the efficacy of the computerized anxiety sensitivity treatment in a guided, group format: A randomized controlled trial. Behav Res Ther. 2025 Aug;191:104785. doi: 10.1016/j.brat.2025.104785. Epub 2025 May 20.

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants were randomized to one of two treatment conditions (active CAST or control HET) and did not receive the other intervention.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Distinguished Research Professor

Study Record Dates

First Submitted

January 27, 2025

First Posted

February 10, 2025

Study Start

February 21, 2024

Primary Completion

January 15, 2025

Study Completion

January 15, 2025

Last Updated

February 10, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations